Robert J. Terifay, SVP Commercial at REGENERON PHARMACEUTICALS INC (REGN), sold 20,000 shares at $64.98 ($1.3M) on 2011-10-11, disclosed to the SEC on 2011-10-11.
Scheduled sale ($1.3M) by SVP Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.78 | 6,198 | $402K | 30.9% |
| 2 | $64.78 | 6,588 | $427K | 32.8% |
| 3 | $64.98 | 402 | $26K | 2.0% |
| 4 | $65.34 | 6,812 | $445K | 34.3% |
| Total | $64.97 avg | 20,000 | $1.3M | 100% |
| Filing → |
| REGN | SELL | 2015-03-18 | $5.0M | — | Filing → |
| REGN | SELL | 2015-02-25 | $4.7M | — | Filing → |
| REGN | SELL | 2014-11-19 | $9.1M | — | Filing → |